How is BPC-157 stored and reconstituted
Medication Overview Vial Size: 6mg Dosage: Inject 0.2mg subcutaneously at bedtime Dosing Schedule Month 1: Inject every night Ongoing: Inject every other night Reconstitution: Mix with 6mL of bacteriostatic water before first use Timing: Does not need to be taken on an empty stomach Storage: Keep refrigerated Duration 1216 weeks consecutively Followed by a 4-week break before restarting for optimal results Vial Longevity: Lasts one month if injecting nightly How to reconstitute Hexarelin and Calculate Dosing Use our easy-to-follow Hexarelin Peptide Calculator to determine your personalized dosing schedule
Interested patients can complete a clinical intake form online, which assesses eligibility for GLP-1 therapy
Next up, the research that really opened our eyes
Tesamorelin Recommended for body recomposition Pros Has been shown to selectively reduce abdominal fat in patients with HIV Can also increase muscle area and strength Promising implications for cognitive and cardiovascular health No reported risk of immunogenicity Cons Studies so far have focused on patients with HIV May cause flu-like symptoms Usually administered by subcutaneous injection Prohibited by the World Anti-Doping Agency Tesamorelin is FDA-approved specifically for HIV-associated lipodystrophy excess abdominal lipid accumulation as a result of antiretroviral therapy its efficacy against which was evidenced in a 2010 clinical trial that demonstrated an 18% decrease in visceral fat in intervention subjects compared to placebo.11 Concerning muscle growth, a later study of HIV patients determined that tesamorelin was effective in increasing skeletal muscle area and density.28 Also, because visceral fat is associated with increased cardiovascular mortality, tesamorelin exhibits promise as a treatment for serious health conditions like heart disease and stroke.37 Although tesamorelin studies so far have understandably centered on patients with HIV, theory holds that the peptide should have the same effects on other users
Konturek SJ, Bielanski W, Kwiecien N, Konturek JW, Czarnobilski K
